Biofourmis Earns FDA’s First-Ever Breakthrough Device Designation for a Novel Digital Therapeutic for Heart Failure
Full Press Release from Biofourmis
BOSTON, July 29, 2021
Full Press Release from Biofourmis
BOSTON, July 29, 2021
MiRXES Secures US$77 Million Series C Funding To Accelerate Multi-Cancer Early Detection Pipeline With Overwhelming Investor Support